Mandlik, V. and Patil, S. and Bopanna, R. and Basu, S. and Singh, S. (2016) Biological Activity of Coumarin Derivatives as Anti-Leishmanial Agents. PLOS ONE , DOI:10 (1371). pp. 1-15.

Preview

Text Dr. Shailza S. (PLoS One) paid open access.pdf - Published Version Download (506Kb) | Preview

Abstract

Cutaneous leishmaniasis affects nearly 0.7 to 1.3 million people annually. Treatment of this disease is difficult due to lack of appropriate medication and the growing problem of drug resistance. Natural compounds such as coumarins serve as complementary therapeutic agents in addition to the current treatment modalities. In this study, we have performed an in-silico screening of the coumarin derivatives and their anti-leishmanial properties has been explored both in-vitro and in-vivo. One of the compounds (compound 2) exhibited leishmanicidal activity and to further study its properties, nanoliposomal formulation of the compound was developed. Treatment of cutaneous lesions in BALB/c mice with compound 2 showed significantly reduced lesion size as compared to the untreated mice (p<0.05) suggesting that compound 2 may possess anti-leishmanial properties.

Item Type:	Article
Additional Information:	This is Open Access article for full text click above weblink.
Subjects:	Bioinformatics and Proteomics
Depositing User:	Mr. Rameshwar Nema
Date Deposited:	15 Nov 2016 02:34
Last Modified:	15 Nov 2016 02:40
URI:	http://nccs.sciencecentral.in/id/eprint/301

Actions (login required)

View Item